SARS-CoV-2 penetrates its target cells via:

Nanotechnology-based solutions may be employed for diagnostics of SARS-CoV-2 infection and for treatment of COVID-19.

Remdesivir is indicated for use in patients with mild-to-moderate disease.

Nanomaterials may be used in what aspects of the prevention of SARS-CoV-2 infection and management of COVID-19:

Conservative management of symptomatic COVID-19 is based on:

Leave a Reply